ArticleJournal of virus eradication2016
Transgender populations and HIV: unique risks, challenges and opportunities.
Article in Journal of virus eradication, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Characteristics of REPRIEVE Trial Participants Identifying Across the Transgender Spectrum.The Journal of infectious diseases · 2020 · on this mapTrial
- Efficacy of an Empowerment-Based, Group-Delivered HIV Prevention Intervention for Young Transgender Women: The Project LifeSkills Randomized Clinical Trial.JAMA pediatrics · 2018Trial
- Review
- Kidney Health and Gender-Affirming Hormone Therapy for Transgender and Gender Diverse Individuals.Clinical journal of the American Society of Nephrology : CJASN · 2026Review
- Review
- A Systematic Review and Meta-Analysis of HIV/AIDS Prevalence Among Transgender Populations Worldwide.Health science reports · 2025Review
- Development and pilot of an interdisciplinary health education program to address health disparities for gender-diverse persons at the U.S./Mexico border.International journal of transgender health · 2025Article
- Neurologic Care for Transgender and Gender-Diverse People: A Review of Current Evidence and Clinical Implications.Neurology. Clinical practice · 2024Review
- Distinct mucosal and systemic immunological characteristics in transgender women potentially relating to HIV acquisition.JCI insight · 2023Article
- Unique HIV Risk Factors and Prevention Needs for Transgender Women and Cisgender Men Who Have Sex with Men in Bangkok, Thailand.Transgender health · 2023Article
- Implementing Gender-Affirming Care in Correctional Settings: A Review of Key Barriers and Action Steps for Change.Journal of correctional health care : the official journal of the National Commission on Correctional Health Care · 2023Review
- Gender Affirmative Care Clinic: An Overview.Indian journal of plastic surgery : official publication of the Association of Plastic Surgeons of India · 2022Review
- Demographic, Behavioral, and Clinical Characteristics of Persons Seeking Care at Sexually Transmitted Disease Clinics - 14 Sites, STD Surveillance Network, United States, 2010-2018.Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002) · 2021Article
- How Has HIV Pre-Exposure Prophylaxis (PrEP) Changed Sex? A Review of Research in a New Era of Bio-behavioral HIV Prevention.Journal of sex research · 2021Review
- Risk Factors for HIV sero-conversion in a high incidence cohort of men who have sex with men and transgender women in Bangkok, Thailand.EClinicalMedicine · 2021Article
- HIV Testing and Associated Characteristics Among Black Cisgender and Transgender Women in the United States.Journal of healthcare, science and the humanities · 2021Article
- Review
- Article
- Human Immunodeficiency Virus and Trans Women: A Literature Review.Transgender health · 2018Review
- Diagnosed HIV Infection in Transgender Adults and Adolescents: Results from the National HIV Surveillance System, 2009-2014.AIDS and behavior · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Due to unique social, behavioural, structural and biological issues, transgender (TG) populations, especially TG women, are at high risk for HIV acquisition. This increased risk is multifactorial, due to differing psychosocial risk factors, poorer access to TG-specific healthcare, a higher likelihood of using exogenous hormones or fillers without direct medical supervision, interactions between hormonal therapy and antiretroviral therapy, and direct effects of hormonal therapy on HIV acquisition and immune control. Further research is needed to elucidate these mechanisms of risk and to help design interventions to reduce HIV risk among transgender populations.
Indexed as
Identifiers
27482441PMC4965251What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.